Global Imatinib Mesylate Drugs Market Growth 2022-2028
- LP 4850256
- 76 Pages
- February 2022
- Pharmaceuticals
The United States Imatinib Mesylate Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Imatinib Mesylate Drugs market, reaching US$ million by the year 2028. As for the Europe Imatinib Mesylate Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Imatinib Mesylate Drugs players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Mesylate Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100mg
400mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Mesylate Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Imatinib Mesylate Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Imatinib Mesylate Drugs by Country/Region, 2017, 2022 & 2028
2.2 Imatinib Mesylate Drugs Segment by Type
2.2.1 100mg
2.2.2 400mg
2.3 Imatinib Mesylate Drugs Sales by Type
2.3.1 Global Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Imatinib Mesylate Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Imatinib Mesylate Drugs Sale Price by Type (2017-2022)
2.4 Imatinib Mesylate Drugs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Imatinib Mesylate Drugs Sales by Application
2.5.1 Global Imatinib Mesylate Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Imatinib Mesylate Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Imatinib Mesylate Drugs Sale Price by Application (2017-2022)
3 Global Imatinib Mesylate Drugs by Company
3.1 Global Imatinib Mesylate Drugs Breakdown Data by Company
3.1.1 Global Imatinib Mesylate Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Imatinib Mesylate Drugs Sales Market Share by Company (2020-2022)
3.2 Global Imatinib Mesylate Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Imatinib Mesylate Drugs Revenue by Company (2020-2022)
3.2.2 Global Imatinib Mesylate Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Imatinib Mesylate Drugs Sale Price by Company
3.4 Key Manufacturers Imatinib Mesylate Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Mesylate Drugs Product Location Distribution
3.4.2 Players Imatinib Mesylate Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Imatinib Mesylate Drugs by Geographic Region
4.1 World Historic Imatinib Mesylate Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Imatinib Mesylate Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Imatinib Mesylate Drugs Annual Revenue by Geographic Region
4.2 World Historic Imatinib Mesylate Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Imatinib Mesylate Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Imatinib Mesylate Drugs Annual Revenue by Country/Region
4.3 Americas Imatinib Mesylate Drugs Sales Growth
4.4 APAC Imatinib Mesylate Drugs Sales Growth
4.5 Europe Imatinib Mesylate Drugs Sales Growth
4.6 Middle East & Africa Imatinib Mesylate Drugs Sales Growth
5 Americas
5.1 Americas Imatinib Mesylate Drugs Sales by Country
5.1.1 Americas Imatinib Mesylate Drugs Sales by Country (2017-2022)
5.1.2 Americas Imatinib Mesylate Drugs Revenue by Country (2017-2022)
5.2 Americas Imatinib Mesylate Drugs Sales by Type
5.3 Americas Imatinib Mesylate Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Mesylate Drugs Sales by Region
6.1.1 APAC Imatinib Mesylate Drugs Sales by Region (2017-2022)
6.1.2 APAC Imatinib Mesylate Drugs Revenue by Region (2017-2022)
6.2 APAC Imatinib Mesylate Drugs Sales by Type
6.3 APAC Imatinib Mesylate Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Imatinib Mesylate Drugs by Country
7.1.1 Europe Imatinib Mesylate Drugs Sales by Country (2017-2022)
7.1.2 Europe Imatinib Mesylate Drugs Revenue by Country (2017-2022)
7.2 Europe Imatinib Mesylate Drugs Sales by Type
7.3 Europe Imatinib Mesylate Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imatinib Mesylate Drugs by Country
8.1.1 Middle East & Africa Imatinib Mesylate Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Imatinib Mesylate Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Imatinib Mesylate Drugs Sales by Type
8.3 Middle East & Africa Imatinib Mesylate Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imatinib Mesylate Drugs
10.3 Manufacturing Process Analysis of Imatinib Mesylate Drugs
10.4 Industry Chain Structure of Imatinib Mesylate Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imatinib Mesylate Drugs Distributors
11.3 Imatinib Mesylate Drugs Customer
12 World Forecast Review for Imatinib Mesylate Drugs by Geographic Region
12.1 Global Imatinib Mesylate Drugs Market Size Forecast by Region
12.1.1 Global Imatinib Mesylate Drugs Forecast by Region (2023-2028)
12.1.2 Global Imatinib Mesylate Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imatinib Mesylate Drugs Forecast by Type
12.7 Global Imatinib Mesylate Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Imatinib Mesylate Drugs Product Offered
13.1.3 Novartis Imatinib Mesylate Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Imatinib Mesylate Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Imatinib Mesylate Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100mg
Table 4. Major Players of 400mg
Table 5. Global Imatinib Mesylate Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Imatinib Mesylate Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Imatinib Mesylate Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Imatinib Mesylate Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Imatinib Mesylate Drugs Revenue by Application (2017-2022)
Table 13. Global Imatinib Mesylate Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Imatinib Mesylate Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Imatinib Mesylate Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Imatinib Mesylate Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Imatinib Mesylate Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Imatinib Mesylate Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Imatinib Mesylate Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Imatinib Mesylate Drugs Producing Area Distribution and Sales Area
Table 21. Players Imatinib Mesylate Drugs Products Offered
Table 22. Imatinib Mesylate Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imatinib Mesylate Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Imatinib Mesylate Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Imatinib Mesylate Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Imatinib Mesylate Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Imatinib Mesylate Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Imatinib Mesylate Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Imatinib Mesylate Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Imatinib Mesylate Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Imatinib Mesylate Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Imatinib Mesylate Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Imatinib Mesylate Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Imatinib Mesylate Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Imatinib Mesylate Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Imatinib Mesylate Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Imatinib Mesylate Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Imatinib Mesylate Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Imatinib Mesylate Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Imatinib Mesylate Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Imatinib Mesylate Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Imatinib Mesylate Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Imatinib Mesylate Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Imatinib Mesylate Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Imatinib Mesylate Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Imatinib Mesylate Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Imatinib Mesylate Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Imatinib Mesylate Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Imatinib Mesylate Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Imatinib Mesylate Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Imatinib Mesylate Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Imatinib Mesylate Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Imatinib Mesylate Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Imatinib Mesylate Drugs
Table 66. Key Market Challenges & Risks of Imatinib Mesylate Drugs
Table 67. Key Industry Trends of Imatinib Mesylate Drugs
Table 68. Imatinib Mesylate Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Imatinib Mesylate Drugs Distributors List
Table 71. Imatinib Mesylate Drugs Customer List
Table 72. Global Imatinib Mesylate Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Imatinib Mesylate Drugs Sales Market Forecast by Region
Table 74. Global Imatinib Mesylate Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Imatinib Mesylate Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Imatinib Mesylate Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Imatinib Mesylate Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Imatinib Mesylate Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Imatinib Mesylate Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Imatinib Mesylate Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Imatinib Mesylate Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Imatinib Mesylate Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Imatinib Mesylate Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Imatinib Mesylate Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Imatinib Mesylate Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Imatinib Mesylate Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Imatinib Mesylate Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Imatinib Mesylate Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Imatinib Mesylate Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Imatinib Mesylate Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Imatinib Mesylate Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis Basic Information, Imatinib Mesylate Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Imatinib Mesylate Drugs Product Offered
Table 94. Novartis Imatinib Mesylate Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
List of Figures
Figure 1. Picture of Imatinib Mesylate Drugs
Figure 2. Imatinib Mesylate Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Mesylate Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Imatinib Mesylate Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Imatinib Mesylate Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100mg
Figure 10. Product Picture of 400mg
Figure 11. Global Imatinib Mesylate Drugs Sales Market Share by Type in 2021
Figure 12. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Imatinib Mesylate Drugs Consumed in Hospital
Figure 14. Global Imatinib Mesylate Drugs Market: Hospital (2017-2022) & (K Units)
Figure 15. Imatinib Mesylate Drugs Consumed in Pharmacy
Figure 16. Global Imatinib Mesylate Drugs Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Imatinib Mesylate Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Imatinib Mesylate Drugs Revenue Market Share by Application in 2021
Figure 19. Imatinib Mesylate Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Imatinib Mesylate Drugs Revenue Market Share by Company in 2021
Figure 21. Global Imatinib Mesylate Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Imatinib Mesylate Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Imatinib Mesylate Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Imatinib Mesylate Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Imatinib Mesylate Drugs Sales 2017-2022 (K Units)
Figure 26. Americas Imatinib Mesylate Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Imatinib Mesylate Drugs Sales 2017-2022 (K Units)
Figure 28. APAC Imatinib Mesylate Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Imatinib Mesylate Drugs Sales 2017-2022 (K Units)
Figure 30. Europe Imatinib Mesylate Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Imatinib Mesylate Drugs Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Imatinib Mesylate Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Imatinib Mesylate Drugs Sales Market Share by Country in 2021
Figure 34. Americas Imatinib Mesylate Drugs Revenue Market Share by Country in 2021
Figure 35. United States Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Imatinib Mesylate Drugs Sales Market Share by Region in 2021
Figure 40. APAC Imatinib Mesylate Drugs Revenue Market Share by Regions in 2021
Figure 41. China Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Imatinib Mesylate Drugs Sales Market Share by Country in 2021
Figure 48. Europe Imatinib Mesylate Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Imatinib Mesylate Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Imatinib Mesylate Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Imatinib Mesylate Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Imatinib Mesylate Drugs in 2021
Figure 62. Manufacturing Process Analysis of Imatinib Mesylate Drugs
Figure 63. Industry Chain Structure of Imatinib Mesylate Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
